Key Information
Source
American College of Cardiology Foundation
Year
2021
summary/abstract
In this episode, Frederick Ruberg, MDexternal link, opens in a new tab, and Mathew Maurer, MDexternal link, opens in a new tab, discuss key topics in cardiac amyloidosis such as the evolving understanding of the epidemiology of the disease, contemporary approaches to diagnosis with an emphasis on noninvasive means, disease course and management of heart failure and conduction disease, as well as the recently approved therapeutics for the two major types of cardiac amyloidosis: light-chain and transthyretin.
Abstract Source
https://www.acc.org/latest-in-cardiology/articles/2021/03/08/13/15/cardiacast_08mar2021?utm_medium=social&utm_source=twitter_post&utm_campaign=twitter_post